Toxic epidermic necrolysis by allopurinol: a case report


Submitted: 30 November 2018
Accepted: 29 March 2019
Published: 18 April 2019
Abstract Views: 1047
PDF: 435
HTML: 54
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Rosa Paola Cerra Geriatric Unit, Pugliese-Ciaccio General Hospital, Catanzaro, Italy.
  • Alberto Castagna Centre for Cognitive Disorders and Dementia, Azienda Sanitaria Provinciale di Catanzaro, Catanzaro, Italy.
  • Laura Greco Geriatric Unit, Pugliese-Ciaccio General Hospital, Catanzaro, Italy.
  • Rosaria Anna Galea Geriatric Unit, Pugliese-Ciaccio General Hospital, Catanzaro, Italy.
  • Maria Lucia Citraro Nephrology and Dialysis Unit, Pugliese-Ciaccio General Hospital, Catanzaro, Italy.
  • Carmen Ruberto Centre for Cognitive Disorders and Dementia, Azienda Sanitaria Provinciale di Catanzaro, Catanzaro, Italy.
  • Giuseppe Coppolino Renal Unit, Department of Health Sciences, Magna Graecia University, Catanzaro; Nephrology and Dialysis Unit, Pugliese-Ciaccio General Hospital, Catanzaro, Italy.
  • Giovanni Ruotolo Geriatric Unit, Pugliese-Ciaccio General Hospital, Catanzaro, Italy.

Toxic epidermal necrolysis (TEN) or Lyell’s syndrome is a rare but serious potentially fatal autoimmune dermatologic disease. It is characterized by cutaneous damage due to apoptosis of the keratinocytes with consequent dermo-epidermal separation for a >30% extension of the body surface, associated with mucosal lesions. It is due to the activation of the immune system, often following the intake of potentially toxic drugs [antibiotics, antiepileptics, non-steroidal antinflammatory drugs (NSAIDs), allopurinol] or after infection with herpetic viruses or mycoplasma. We describe the case of an 82- year-old man starting therapy of Allopurinol for hyperuricemia. After four days the patient shows an extensive erythematous rash localized to the trunk and upper limbs. The following day the rash also involves the face, tending to the confluence and after another two days, the macules turn into de-epithelized areas because of dermo-epidermal separation and the lesions involve the oral and ocular mucosa, causing dysphagia and difficulty in speaking. He was treated with steroid and antihistamine therapy, suspending the previously undertaken therapy with antibiotic and Allopurinol.


Cerra, R. P., Castagna, A., Greco, L., Galea, R. A., Citraro, M. L., Ruberto, C., Coppolino, G., & Ruotolo, G. (2019). Toxic epidermic necrolysis by allopurinol: a case report. Geriatric Care, 5(1). https://doi.org/10.4081/gc.2019.7958

Downloads

Download data is not yet available.

Citations